Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering alleles
Gregson, JM
; Freitag, DF; Surendran, P; Stitziel, NO; Chowdhury, R; Burgess, S; Kaptoge, S; Gao, P; Staley, JR; Willeit, P; +51 more...Nielsen, SF; Caslake, M; Trompet, S; Polfus, LM; Kuulasmaa, K; Kontto, J; Perola, M; Blankenberg, S; Veronesi, G; Gianfagna, F; Männistö, S; Kimura, A; Lin, H; Reilly, DF; Gorski, M; Mijatovic, V; Munroe, PB; Ehret, GB; Thompson, A; Uria-Nickelsen, M; Malarstig, A; Dehghan, A; Vogt, TF; Sasaoka, T; Takeuchi, F; Kato, N; Yamada, Y; Kee, F; Müller-Nurasyid, M; Ferrières, J; Arveiler, D; Amouyel, P; Salomaa, V; Boerwinkle, E; Thompson, SG; Ford, I; Wouter Jukema, J; Sattar, N; Packard, CJ; Shafi Majumder, Aa; Alam, DS; Deloukas, P; Schunkert, H; Samani, NJ; Kathiresan, S; Nordestgaard, BG; Saleheen, D; Howson, JM; Di Angelantonio, E; Butterworth, AS; Danesh, J and
(2017)
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering alleles.
European Journal of Preventive Cardiology, 24 (5).
pp. 492-504.
ISSN 2047-4873
DOI: 10.1177/2047487316682186
Item Type | Article |
---|---|
Date Deposited | 04 Jan 2019 11:17 |
ORCID: https://orcid.org/0000-0001-6084-166X